Psyence Biomedical Ltd (NASDAQ: PBM) is -99.53% lower on its value in year-to-date trading and has touched a low of $0.04 and a high of $14.55 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PBM stock was last observed hovering at around $0.05 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $0.04, the stock is -34.06% and -52.56% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 10.51 million and changing -7.45% at the moment leaves the stock -92.08% off its SMA200. PBM registered -99.60% loss for a year compared to 6-month loss of -94.75%. The firm has a 50-day simple moving average (SMA 50) of $0.091694 and a 200-day simple moving average (SMA200) of $0.5472089.
The stock witnessed a -53.72% gain in the last 1 month and extending the period to 3 months gives it a -90.35%, and is -14.03% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 14.79% over the week and 16.58% over the month.
Psyence Biomedical Ltd (PBM) has around 10 employees, a market worth around $2.55M and $0.00M in sales. Distance from 52-week low is -1.14% and -99.70% from its 52-week high.
.
Psyence Biomedical Ltd (PBM) Top Institutional Holders
The shares outstanding are 54.33M, and float is at 46.96M with Short Float at 1.43%.
Psyence Biomedical Ltd (PBM) Insider Activity
#####
